Ionis director Michael R. Hayden reports acquisition of 20,000 common shares worth $1,059,000

Reuters2026/07/31 20:43

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ionis Pharmaceuticals director Michael R. Hayden reported spouse-affiliated purchases totaling 20,000 common shares at about $52.94 per share.
Spouse-linked holdings rose to 24,000 shares held indirectly.
Hayden reported 54,298 Ionis common shares held directly following the filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ionis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000874015-26-000254), on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ionis director Michael R. Hayden reports acquisition of 20,000 common shares worth $1,059,000

You may also like

Crypto prices